论文部分内容阅读
目的观察普乐林对脑梗死病人的临床疗效。方法将近两年间诊治的急性脑梗死220例，其中治疗组120例，对照组100例，按统一方案进行观察。治疗组加用普乐林静滴，并与对照组进行比较。结果：治疗组基本痊愈加显著进步91例（75．8％），对照组44例（44%），两级比较有极显著差异（P＜0．01）。结论：普乐林治疗急性脑梗死效果显著，是临床应用切实有效的药物。
Objective To observe the clinical efficacy of pullarin in patients with cerebral infarction. Methods A total of 220 acute cerebral infarction patients were diagnosed and treated in the recent two years, including 120 cases in the treatment group and 100 cases in the control group. The treatment group was given praline intravenously and compared with the control group. Results: In the treatment group, 91 cases (75.8%) were cured and 44 cases (44%) were cured. There was significant difference between the two groups (P <0.01). Conclusion: Pulleline is effective in the treatment of acute cerebral infarction and is an effective and effective drug in clinical practice.